Oxaliplatin Market - Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 19-Jan-2022
No. of pages: 119

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

In this report, only the finished drug is covered, exclude API.

This report contains market size and forecasts of Oxaliplatin in Global, including the following market information:

Global Oxaliplatin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Oxaliplatin market was valued at 923.5 million in 2021 and is projected to reach US$ 1636.5 million by 2028, at a CAGR of 8.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Mannitol Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oxaliplatin include Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan and Jiangsu Hengrui Medicine, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oxaliplatin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oxaliplatin Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Oxaliplatin Market Segment Percentages, by Type, 2021 (%)

- Mannitol

- Glucose Solution

- Lactose Solution

- Others

Global Oxaliplatin Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Oxaliplatin Market Segment Percentages, by Application, 2021 (%)

- Colorectal Cancer

- Stomach Cancer

- Ovarian Cancer

- Others

Global Oxaliplatin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Oxaliplatin Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oxaliplatin revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Oxaliplatin revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Sanofi-Aventis

- Yakult honsha

- Dr Reddy's laboratories

- Sun Pharmaceutical

- Teva

- Fresenius Kabi

- Hospira

- Mylan

- Jiangsu Hengrui Medicine

- Nanjing Pharmaceutical Factory

- Jiangsu Aosaikang Pharmaceutical

- Qilu Pharmaceutical

- Hisun Pharmaceutical

- Lunan Pharmaceutical

- Luoxin

- Halfsky Pharmacy

- YRPG

- Hainan Jinrui Pharmaceutical

- Jari Pharmaceutical

- Chiatai Tianqing

Oxaliplatin Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Oxaliplatin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oxaliplatin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oxaliplatin Overall Market Size
2.1 Global Oxaliplatin Market Size: 2021 VS 2028
2.2 Global Oxaliplatin Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oxaliplatin Players in Global Market
3.2 Top Global Oxaliplatin Companies Ranked by Revenue
3.3 Global Oxaliplatin Revenue by Companies
3.4 Top 3 and Top 5 Oxaliplatin Companies in Global Market, by Revenue in 2021
3.5 Global Companies Oxaliplatin Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oxaliplatin Players in Global Market
3.6.1 List of Global Tier 1 Oxaliplatin Companies
3.6.2 List of Global Tier 2 and Tier 3 Oxaliplatin Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Oxaliplatin Market Size Markets, 2021 & 2028
4.1.2 Mannitol
4.1.3 Glucose Solution
4.1.4 Lactose Solution
4.1.5 Others
4.2 By Type - Global Oxaliplatin Revenue & Forecasts
4.2.1 By Type - Global Oxaliplatin Revenue, 2017-2022
4.2.2 By Type - Global Oxaliplatin Revenue, 2023-2028
4.2.3 By Type - Global Oxaliplatin Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oxaliplatin Market Size, 2021 & 2028
5.1.2 Colorectal Cancer
5.1.3 Stomach Cancer
5.1.4 Ovarian Cancer
5.1.5 Others
5.2 By Application - Global Oxaliplatin Revenue & Forecasts
5.2.1 By Application - Global Oxaliplatin Revenue, 2017-2022
5.2.2 By Application - Global Oxaliplatin Revenue, 2023-2028
5.2.3 By Application - Global Oxaliplatin Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Oxaliplatin Market Size, 2021 & 2028
6.2 By Region - Global Oxaliplatin Revenue & Forecasts
6.2.1 By Region - Global Oxaliplatin Revenue, 2017-2022
6.2.2 By Region - Global Oxaliplatin Revenue, 2023-2028
6.2.3 By Region - Global Oxaliplatin Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Oxaliplatin Revenue, 2017-2028
6.3.2 US Oxaliplatin Market Size, 2017-2028
6.3.3 Canada Oxaliplatin Market Size, 2017-2028
6.3.4 Mexico Oxaliplatin Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Oxaliplatin Revenue, 2017-2028
6.4.2 Germany Oxaliplatin Market Size, 2017-2028
6.4.3 France Oxaliplatin Market Size, 2017-2028
6.4.4 U.K. Oxaliplatin Market Size, 2017-2028
6.4.5 Italy Oxaliplatin Market Size, 2017-2028
6.4.6 Russia Oxaliplatin Market Size, 2017-2028
6.4.7 Nordic Countries Oxaliplatin Market Size, 2017-2028
6.4.8 Benelux Oxaliplatin Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Oxaliplatin Revenue, 2017-2028
6.5.2 China Oxaliplatin Market Size, 2017-2028
6.5.3 Japan Oxaliplatin Market Size, 2017-2028
6.5.4 South Korea Oxaliplatin Market Size, 2017-2028
6.5.5 Southeast Asia Oxaliplatin Market Size, 2017-2028
6.5.6 India Oxaliplatin Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Oxaliplatin Revenue, 2017-2028
6.6.2 Brazil Oxaliplatin Market Size, 2017-2028
6.6.3 Argentina Oxaliplatin Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oxaliplatin Revenue, 2017-2028
6.7.2 Turkey Oxaliplatin Market Size, 2017-2028
6.7.3 Israel Oxaliplatin Market Size, 2017-2028
6.7.4 Saudi Arabia Oxaliplatin Market Size, 2017-2028
6.7.5 UAE Oxaliplatin Market Size, 2017-2028
7 Players Profiles
7.1 Sanofi-Aventis
7.1.1 Sanofi-Aventis Corporate Summary
7.1.2 Sanofi-Aventis Business Overview
7.1.3 Sanofi-Aventis Oxaliplatin Major Product Offerings
7.1.4 Sanofi-Aventis Oxaliplatin Revenue in Global Market (2017-2022)
7.1.5 Sanofi-Aventis Key News
7.2 Yakult honsha
7.2.1 Yakult honsha Corporate Summary
7.2.2 Yakult honsha Business Overview
7.2.3 Yakult honsha Oxaliplatin Major Product Offerings
7.2.4 Yakult honsha Oxaliplatin Revenue in Global Market (2017-2022)
7.2.5 Yakult honsha Key News
7.3 Dr Reddy's laboratories
7.3.1 Dr Reddy's laboratories Corporate Summary
7.3.2 Dr Reddy's laboratories Business Overview
7.3.3 Dr Reddy's laboratories Oxaliplatin Major Product Offerings
7.3.4 Dr Reddy's laboratories Oxaliplatin Revenue in Global Market (2017-2022)
7.3.5 Dr Reddy's laboratories Key News
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Corporate Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Oxaliplatin Major Product Offerings
7.4.4 Sun Pharmaceutical Oxaliplatin Revenue in Global Market (2017-2022)
7.4.5 Sun Pharmaceutical Key News
7.5 Teva
7.5.1 Teva Corporate Summary
7.5.2 Teva Business Overview
7.5.3 Teva Oxaliplatin Major Product Offerings
7.5.4 Teva Oxaliplatin Revenue in Global Market (2017-2022)
7.5.5 Teva Key News
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Corporate Summary
7.6.2 Fresenius Kabi Business Overview
7.6.3 Fresenius Kabi Oxaliplatin Major Product Offerings
7.6.4 Fresenius Kabi Oxaliplatin Revenue in Global Market (2017-2022)
7.6.5 Fresenius Kabi Key News
7.7 Hospira
7.7.1 Hospira Corporate Summary
7.7.2 Hospira Business Overview
7.7.3 Hospira Oxaliplatin Major Product Offerings
7.7.4 Hospira Oxaliplatin Revenue in Global Market (2017-2022)
7.7.5 Hospira Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Oxaliplatin Major Product Offerings
7.8.4 Mylan Oxaliplatin Revenue in Global Market (2017-2022)
7.8.5 Mylan Key News
7.9 Jiangsu Hengrui Medicine
7.9.1 Jiangsu Hengrui Medicine Corporate Summary
7.9.2 Jiangsu Hengrui Medicine Business Overview
7.9.3 Jiangsu Hengrui Medicine Oxaliplatin Major Product Offerings
7.9.4 Jiangsu Hengrui Medicine Oxaliplatin Revenue in Global Market (2017-2022)
7.9.5 Jiangsu Hengrui Medicine Key News
7.10 Nanjing Pharmaceutical Factory
7.10.1 Nanjing Pharmaceutical Factory Corporate Summary
7.10.2 Nanjing Pharmaceutical Factory Business Overview
7.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Major Product Offerings
7.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Revenue in Global Market (2017-2022)
7.10.5 Nanjing Pharmaceutical Factory Key News
7.11 Jiangsu Aosaikang Pharmaceutical
7.11.1 Jiangsu Aosaikang Pharmaceutical Corporate Summary
7.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview
7.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Major Product Offerings
7.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue in Global Market (2017-2022)
7.11.5 Jiangsu Aosaikang Pharmaceutical Key News
7.12 Qilu Pharmaceutical
7.12.1 Qilu Pharmaceutical Corporate Summary
7.12.2 Qilu Pharmaceutical Business Overview
7.12.3 Qilu Pharmaceutical Oxaliplatin Major Product Offerings
7.12.4 Qilu Pharmaceutical Oxaliplatin Revenue in Global Market (2017-2022)
7.12.5 Qilu Pharmaceutical Key News
7.13 Hisun Pharmaceutical
7.13.1 Hisun Pharmaceutical Corporate Summary
7.13.2 Hisun Pharmaceutical Business Overview
7.13.3 Hisun Pharmaceutical Oxaliplatin Major Product Offerings
7.13.4 Hisun Pharmaceutical Oxaliplatin Revenue in Global Market (2017-2022)
7.13.5 Hisun Pharmaceutical Key News
7.14 Lunan Pharmaceutical
7.14.1 Lunan Pharmaceutical Corporate Summary
7.14.2 Lunan Pharmaceutical Business Overview
7.14.3 Lunan Pharmaceutical Oxaliplatin Major Product Offerings
7.14.4 Lunan Pharmaceutical Oxaliplatin Revenue in Global Market (2017-2022)
7.14.5 Lunan Pharmaceutical Key News
7.15 Luoxin
7.15.1 Luoxin Corporate Summary
7.15.2 Luoxin Business Overview
7.15.3 Luoxin Oxaliplatin Major Product Offerings
7.15.4 Luoxin Oxaliplatin Revenue in Global Market (2017-2022)
7.15.5 Luoxin Key News
7.16 Halfsky Pharmacy
7.16.1 Halfsky Pharmacy Corporate Summary
7.16.2 Halfsky Pharmacy Business Overview
7.16.3 Halfsky Pharmacy Oxaliplatin Major Product Offerings
7.16.4 Halfsky Pharmacy Oxaliplatin Revenue in Global Market (2017-2022)
7.16.5 Halfsky Pharmacy Key News
7.17 YRPG
7.17.1 YRPG Corporate Summary
7.17.2 YRPG Business Overview
7.17.3 YRPG Oxaliplatin Major Product Offerings
7.17.4 YRPG Oxaliplatin Revenue in Global Market (2017-2022)
7.17.5 YRPG Key News
7.18 Hainan Jinrui Pharmaceutical
7.18.1 Hainan Jinrui Pharmaceutical Corporate Summary
7.18.2 Hainan Jinrui Pharmaceutical Business Overview
7.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Major Product Offerings
7.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue in Global Market (2017-2022)
7.18.5 Hainan Jinrui Pharmaceutical Key News
7.19 Jari Pharmaceutical
7.19.1 Jari Pharmaceutical Corporate Summary
7.19.2 Jari Pharmaceutical Business Overview
7.19.3 Jari Pharmaceutical Oxaliplatin Major Product Offerings
7.19.4 Jari Pharmaceutical Oxaliplatin Revenue in Global Market (2017-2022)
7.19.5 Jari Pharmaceutical Key News
7.20 Chiatai Tianqing
7.20.1 Chiatai Tianqing Corporate Summary
7.20.2 Chiatai Tianqing Business Overview
7.20.3 Chiatai Tianqing Oxaliplatin Major Product Offerings
7.20.4 Chiatai Tianqing Oxaliplatin Revenue in Global Market (2017-2022)
7.20.5 Chiatai Tianqing Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Oxaliplatin Market Opportunities & Trends in Global Market
Table 2. Oxaliplatin Market Drivers in Global Market
Table 3. Oxaliplatin Market Restraints in Global Market
Table 4. Key Players of Oxaliplatin in Global Market
Table 5. Top Oxaliplatin Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Oxaliplatin Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Oxaliplatin Revenue Share by Companies, 2017-2022
Table 8. Global Companies Oxaliplatin Product Type
Table 9. List of Global Tier 1 Oxaliplatin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oxaliplatin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Oxaliplatin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Oxaliplatin Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Oxaliplatin Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Oxaliplatin Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Oxaliplatin Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Oxaliplatin Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Oxaliplatin Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Oxaliplatin Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Oxaliplatin Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Oxaliplatin Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Oxaliplatin Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Oxaliplatin Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Oxaliplatin Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Oxaliplatin Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Oxaliplatin Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Oxaliplatin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Oxaliplatin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Oxaliplatin Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Oxaliplatin Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi-Aventis Corporate Summary
Table 31. Sanofi-Aventis Oxaliplatin Product Offerings
Table 32. Sanofi-Aventis Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 33. Yakult honsha Corporate Summary
Table 34. Yakult honsha Oxaliplatin Product Offerings
Table 35. Yakult honsha Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 36. Dr Reddy's laboratories Corporate Summary
Table 37. Dr Reddy's laboratories Oxaliplatin Product Offerings
Table 38. Dr Reddy's laboratories Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 39. Sun Pharmaceutical Corporate Summary
Table 40. Sun Pharmaceutical Oxaliplatin Product Offerings
Table 41. Sun Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 42. Teva Corporate Summary
Table 43. Teva Oxaliplatin Product Offerings
Table 44. Teva Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 45. Fresenius Kabi Corporate Summary
Table 46. Fresenius Kabi Oxaliplatin Product Offerings
Table 47. Fresenius Kabi Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 48. Hospira Corporate Summary
Table 49. Hospira Oxaliplatin Product Offerings
Table 50. Hospira Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 51. Mylan Corporate Summary
Table 52. Mylan Oxaliplatin Product Offerings
Table 53. Mylan Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 54. Jiangsu Hengrui Medicine Corporate Summary
Table 55. Jiangsu Hengrui Medicine Oxaliplatin Product Offerings
Table 56. Jiangsu Hengrui Medicine Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 57. Nanjing Pharmaceutical Factory Corporate Summary
Table 58. Nanjing Pharmaceutical Factory Oxaliplatin Product Offerings
Table 59. Nanjing Pharmaceutical Factory Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 60. Jiangsu Aosaikang Pharmaceutical Corporate Summary
Table 61. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product Offerings
Table 62. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 63. Qilu Pharmaceutical Corporate Summary
Table 64. Qilu Pharmaceutical Oxaliplatin Product Offerings
Table 65. Qilu Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 66. Hisun Pharmaceutical Corporate Summary
Table 67. Hisun Pharmaceutical Oxaliplatin Product Offerings
Table 68. Hisun Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 69. Lunan Pharmaceutical Corporate Summary
Table 70. Lunan Pharmaceutical Oxaliplatin Product Offerings
Table 71. Lunan Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 72. Luoxin Corporate Summary
Table 73. Luoxin Oxaliplatin Product Offerings
Table 74. Luoxin Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 75. Halfsky Pharmacy Corporate Summary
Table 76. Halfsky Pharmacy Oxaliplatin Product Offerings
Table 77. Halfsky Pharmacy Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 78. YRPG Corporate Summary
Table 79. YRPG Oxaliplatin Product Offerings
Table 80. YRPG Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 81. Hainan Jinrui Pharmaceutical Corporate Summary
Table 82. Hainan Jinrui Pharmaceutical Oxaliplatin Product Offerings
Table 83. Hainan Jinrui Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 84. Jari Pharmaceutical Corporate Summary
Table 85. Jari Pharmaceutical Oxaliplatin Product Offerings
Table 86. Jari Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2017-2022)
Table 87. Chiatai Tianqing Corporate Summary
Table 88. Chiatai Tianqing Oxaliplatin Product Offerings
Table 89. Chiatai Tianqing Oxaliplatin Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Oxaliplatin Segment by Type in 2021
Figure 2. Oxaliplatin Segment by Application in 2021
Figure 3. Global Oxaliplatin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Oxaliplatin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oxaliplatin Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oxaliplatin Revenue in 2021
Figure 8. By Type - Global Oxaliplatin Revenue Market Share, 2017-2028
Figure 9. By Application - Global Oxaliplatin Revenue Market Share, 2017-2028
Figure 10. By Region - Global Oxaliplatin Revenue Market Share, 2017-2028
Figure 11. By Country - North America Oxaliplatin Revenue Market Share, 2017-2028
Figure 12. US Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Oxaliplatin Revenue Market Share, 2017-2028
Figure 16. Germany Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 17. France Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Oxaliplatin Revenue Market Share, 2017-2028
Figure 24. China Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 28. India Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Oxaliplatin Revenue Market Share, 2017-2028
Figure 30. Brazil Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Oxaliplatin Revenue Market Share, 2017-2028
Figure 33. Turkey Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Oxaliplatin Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi-Aventis Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Yakult honsha Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Dr Reddy's laboratories Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sun Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Fresenius Kabi Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Hospira Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Mylan Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Jiangsu Hengrui Medicine Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Nanjing Pharmaceutical Factory Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Qilu Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Hisun Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Lunan Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Luoxin Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Halfsky Pharmacy Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. YRPG Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Hainan Jinrui Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Jari Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Chiatai Tianqing Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs